Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BGP-15 for prevention of hospitalisation in newly diagnosed high-risk COVID-19 patients
2020-005539-62Phase 2Terminated
- Sponsor
- Mitochon Technologies
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing BGP-15 with Placebo (2 arms). Started Jan 2021; status: terminated.
02
Drugs
BGP-15
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-005539-62.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005539-62.